Dynamic42 receives EY Public Value Award

15. October 2018 In News

EY Public Value Award – Dynamic42 GmbH honoured

Dynamic42 GmbH was awarded the audience prize at this year’s EY Public Value Award. At the evening event on 11 October 2018 at the Congress Centre at the Zoo in Leipzig, Managing Directors Dr Knut Rennert and Martin Raasch won over the audience with their pitch. “We were very surprised and delighted. The personal response also showed us that the topic of alternative methods to animal testing in basic research and pharmaceutical development concerns many people,” says Knut Rennert. The competition was strong with the alternative online search engine Ecosia, the medical technology start-up MOIO GmbH and the Berlin start-ups Selfapy GmbH, CODE University of Applied Sciences GmbH, call a midwife and REDI School of Digital Integration gGmbH.

The prize was established in 2015 by Prof. Dr. Timo Meynhardt and Dr. Justus von Grone from HHL Leipzig through their many years of research into the common good of organisations and has been awarded annually since 2016 by the auditing firm Ernst & Young to young start-ups that make a special contribution to the common good.

Press Release | Tumour-on-chip model supports preclinical drug development on pancreatic cancer

Dynamic42 and Heinrich Heine University have developed a tumour-on-a-chip model that replicates the microenvironment of pancreatic ductal adenocarcinoma (PDAC). This 3D model allows for realistic drug testing and could accelerate the development of personalized therapies.

Press Release | Dynamic42 and research partners present three-organ system to reduce animal testing

Dynamic42, in collaboration with ESQlabs, Bayer, and the Placenta Lab, has developed an innovative three-organ system with the potential to reduce animal testing in pharmaceutical research.